← Back to headlines
AbbVie Inc. Announces EC Authorization for Expanded VENCLYXTO® Label
AbbVie Inc. has announced that the European Commission has granted authorization for an expanded label for its drug VENCLYXTO®.
2 Jun, 14:42 — 2 Jun, 14:42
Sources
Showing 1 of 1 sources
